These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29356689)

  • 1. The impact of myeloperoxidase on HDL function in myocardial infarction.
    Tietge UJF
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):137-142. PubMed ID: 29356689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.
    Khine HW; Teiber JF; Haley RW; Khera A; Ayers CR; Rohatgi A
    Atherosclerosis; 2017 Aug; 263():156-162. PubMed ID: 28645072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: implications for cardiac outcome.
    Dullaart RP; Tietge UJ; Kwakernaak AJ; Dikkeschei BD; Perton F; Tio RA
    Atherosclerosis; 2014 May; 234(1):185-92. PubMed ID: 24661908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.
    Cavusoglu E; Ruwende C; Eng C; Chopra V; Yanamadala S; Clark LT; Pinsky DJ; Marmur JD
    Am J Cardiol; 2007 May; 99(10):1364-8. PubMed ID: 17493461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction.
    Mocatta TJ; Pilbrow AP; Cameron VA; Senthilmohan R; Frampton CM; Richards AM; Winterbourn CC
    J Am Coll Cardiol; 2007 May; 49(20):1993-2000. PubMed ID: 17512353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.
    Wang G; Mathew AV; Yu H; Li L; He L; Gao W; Liu X; Guo Y; Byun J; Zhang J; Chen YE; Pennathur S
    PLoS One; 2018; 13(3):e0193782. PubMed ID: 29505607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.
    Zheng L; Nukuna B; Brennan ML; Sun M; Goormastic M; Settle M; Schmitt D; Fu X; Thomson L; Fox PL; Ischiropoulos H; Smith JD; Kinter M; Hazen SL
    J Clin Invest; 2004 Aug; 114(4):529-41. PubMed ID: 15314690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction.
    Zeller M; Masson D; Farnier M; Lorgis L; Deckert V; Pais de Barros JP; Desrumaux C; Sicard P; Grober J; Blache D; Gambert P; Rochette L; Cottin Y; Lagrost L
    J Am Coll Cardiol; 2007 Nov; 50(20):1948-55. PubMed ID: 17996559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction.
    Khan SQ; Kelly D; Quinn P; Davies JE; Ng LL
    Heart; 2007 Jul; 93(7):826-31. PubMed ID: 17194712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels.
    Annema W; Willemsen HM; de Boer JF; Dikkers A; van der Giet M; Nieuwland W; Muller Kobold AC; van Pelt LJ; Slart RH; van der Horst IC; Dullaart RP; Tio RA; Tietge UJ
    J Clin Lipidol; 2016; 10(6):1318-1328. PubMed ID: 27919348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease).
    Rathnayake N; Gustafsson A; Norhammar A; Kjellström B; Klinge B; Rydén L; Tervahartiala T; Sorsa T;
    PLoS One; 2015; 10(7):e0126370. PubMed ID: 26132583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase is not associated with scintigraphic myocardial perfusion abnormalities in type 2 diabetic patients with mild stable anginal complaints.
    Wiersma JJ; Verberne HJ; Meuwese MC; Stroes ES; van Miert JN; van Eck-Smit BL; Tijssen JG; Piek JJ; Trip MD
    Clin Chim Acta; 2011 Jan; 412(1-2):86-90. PubMed ID: 20869358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
    Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J
    Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?
    Schindhelm RK; van der Zwan LP; Teerlink T; Scheffer PG
    Clin Chem; 2009 Aug; 55(8):1462-70. PubMed ID: 19556446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between HDL particles size and myeloperoxidase/ paraoxonase-1 (MPO/PON1) ratio in patients with acute coronary syndrome.
    Emami Razavi A; Basati G; Varshosaz J; Abdi S
    Acta Med Iran; 2013 Jul; 51(6):365-71. PubMed ID: 23852840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
    Kimak E; Zięba B; Duma D; Solski J
    Lipids Health Dis; 2018 Apr; 17(1):71. PubMed ID: 29618370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
    Yunoki K; Naruko T; Inaba M; Inoue T; Nakagawa M; Sugioka K; Ohsawa M; Iwasa Y; Komatsu R; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
    Atherosclerosis; 2013 Dec; 231(2):308-14. PubMed ID: 24267244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein levels are strongly associated with the recovery rate of insulin sensitivity during the acute phase of myocardial infarction: a study by euglycemic hyperinsulinemic clamp.
    Carvalho LS; Martins NV; Moura FA; Cintra RM; Almeida OL; Quinaglia e Silva JC; Sposito AC;
    J Clin Lipidol; 2013; 7(1):24-8. PubMed ID: 23351579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Metformin on Metabolites and Relation With Myocardial Infarct Size and Left Ventricular Ejection Fraction After Myocardial Infarction.
    Eppinga RN; Kofink D; Dullaart RP; Dalmeijer GW; Lipsic E; van Veldhuisen DJ; van der Horst IC; Asselbergs FW; van der Harst P
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.